Ack1 inhibitor 2, identified by its CAS number 1196392-26-3, is a small molecule compound that serves as an inhibitor of the Ack1 (Activated Cdc42-associated kinase 1) enzyme. This compound is primarily studied for its potential therapeutic applications in cancer treatment, as Ack1 is implicated in various signaling pathways that promote tumor growth and metastasis. The characteristics of Ack1 inhibitor 2 include its ability to selectively inhibit Ack1 activity, thereby disrupting downstream signaling processes associated with cell proliferation and survival. The compound typically exhibits moderate to high solubility in organic solvents and may have specific binding affinities that facilitate its role as an inhibitor. Additionally, it is often evaluated for its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion (ADME), to assess its viability as a drug candidate. Research into Ack1 inhibitor 2 continues to explore its efficacy, safety profile, and potential combination therapies in oncological settings.

Ack1 inhibitor 2

1196392-26-3: Ack1 inhibitor 2, identified by its CAS number 1196392-26-3, is a small molecule compound that serves as an inhibitor of the Ack1 (Activated Cdc42-associated kinase 1) enzyme. This compound is primarily studied for its potential therapeutic applications in cancer treatment, as Ack1 is implicated in various signaling pathways that promote tumor growth and metastasis. The characteristics of Ack1 inhibitor 2 include its ability to selectively inhibit Ack1 activity, thereby disrupting downstream signaling processes associated with cell proliferation and survival. The compound typically exhibits moderate to high solubility in organic solvents and may have specific binding affinities that facilitate its role as an inhibitor. Additionally, it is often evaluated for its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion (ADME), to assess its viability as a drug candidate. Research into Ack1 inhibitor 2 continues to explore its efficacy, safety profile, and potential combination therapies in oncological settings.

<p>Ack1 Inhibitor 2, also referred to as Example 259, effectively inhibits Ack1 with an IC50 value of 0.46 μM [1].</p>

CAS 1196392-26-3

Ack1 inhibitor 2

Ack1 inhibitor 2

Ref: TM-T85584